Innovate UK Medicines Manufacturing Strand 2

Fund Name: Medicines Manufacturing Strand 2
Project Length: 12 and 30 months
Project Value: Share of £10M
Deadline: 09/05/2018

This competition aims to stimulate the development of innovative methods or technologies to improve the manufacture of novel medicines for human use. ‘Novel’ medicines are those that have not yet been commercially launched on the market but may have been applied as part of clinical trials or under exemptions from the UK Human Medicines Regulations.

Your proposals can include, but are not limited to, approaches that have the potential to deliver:

  • improved commercially viable manufacturing processes
  • methods for the reliable and robust scale-up of production of novel medicines
  • increased yield of active ingredient
  • lower cost of production and goods

In this competition medicines that are in scope and can be used as examplar products are limited to:

  • advanced therapy medicinal products
  • natural product medicines
  • nucleic acid-based drugs
  • prophylactic vaccines
  • protein or peptide biopharmaceuticals
  • small molecular weight pharmaceuticals
  • virus and phage therapeutic

Your project can focus on technical feasibility, industrial research or experimental development.

To be eligible for funding you must:

be a UK-based business, academic organisation, charity, public sector organisation or research and technology organisation (RTO)
carry out your project work in the UK
intend to exploit the results from the UK
Up to £10 million is available to fund innovation projects in this competition. Up to £1 million is available to fund projects with eligible costs of up to £100,000 and 6 to 12 months in duration. Up to £9 million is available to fund projects with eligible costs of up to £1.5 million and between 12 and 30 months in duration.

If you think that you might be eligible for any of these funds, please contact us – we’re happy to discuss your eligibility over the phone or email. Please call 01392 427860 or email

Back to all funds